Michael G. Fitzpatrick
Michael G. Fitzpatrick is a Republican member of the U.S. House of Representatives from PA. Across the disclosures we track, Michael G. Fitzpatrick has reported 18 stock trades — 8 purchases and 10 sales — worth an estimated $168,500 at the midpoints of the disclosed ranges, leaning toward selling. The most frequently traded position is COV (Covidien plc. ordinary Shares), appearing in 2 disclosures. The most recent disclosed transaction was on Apr 10, 2015. Under the STOCK Act, members must report trades within 45 days — each row below links to the original House filing.
Michael G. Fitzpatrick's trading activity
Michael G. Fitzpatrick's disclosed trades
| Disclosed | Traded | Ticker | Type | Amount | Since disclosed | Owner | |
|---|---|---|---|---|---|---|---|
| May 8, 2015 | Apr 10, 2015 | DD | Sale | $1,001 - $15,000 | — | Self | filing ↗ |
| Feb 6, 2015 | Jan 27, 2015 | CL | Purchase | $1,001 - $15,000 | +70.7% | Self | filing ↗ |
| Feb 6, 2015 | Jan 27, 2015 | MCD | Sale | $1,001 - $15,000 | — | Self | filing ↗ |
| Feb 6, 2015 | Jan 27, 2015 | MET | Purchase | $1,001 - $15,000 | +212.9% | Self | filing ↗ |
| Feb 6, 2015 | Jan 27, 2015 | TD | Sale | $1,001 - $15,000 | — | Self | filing ↗ |
| Nov 6, 2014 | Oct 15, 2014 | HON | Purchase | $1,001 - $15,000 | +220.0% | Self | filing ↗ |
| Oct 7, 2014 | Sep 19, 2014 | CVX | Sale | $1,001 - $15,000 | — | Self | filing ↗ |
| Sep 5, 2014 | Aug 7, 2014 | COV | Sale | $1,001 - $15,000 | — | Self | filing ↗ |
| Jul 8, 2014 | Jun 4, 2014 | CAG | Sale | $1,001 - $15,000 | — | Self | filing ↗ |
| Jul 8, 2014 | Jun 4, 2014 | PNR | Purchase | $1,001 - $15,000 | +87.2% | Self | filing ↗ |
| Apr 5, 2014 | Mar 20, 2014 | COV | Purchase | $1,001 - $15,000 | — | Self | filing ↗ |
| Mar 6, 2014 | Feb 21, 2014 | IVW | Sale | $15,001 - $50,000 | — | Self | filing ↗ |
| Mar 6, 2014 | Feb 21, 2014 | WFC | Purchase | $1,001 - $15,000 | +152.7% | Self | filing ↗ |
| Feb 5, 2014 | Jan 9, 2014 | BCE | Sale | $1,001 - $15,000 | — | Self | filing ↗ |
| Feb 5, 2014 | Jan 9, 2014 | PEP | Purchase | $1,001 - $15,000 | +152.7% | Self | filing ↗ |
| Jan 13, 2014 | Dec 13, 2013 | CMS | Sale | $1,001 - $15,000 | — | Self | filing ↗ |
| Jan 13, 2014 | Dec 13, 2013 | IYR | Purchase | $1,001 - $15,000 | — | Self | filing ↗ |
| Jan 13, 2014 | Dec 13, 2013 | VTR | Sale | $1,001 - $15,000 | — | Self | filing ↗ |
Most-traded stocks
Michael G. Fitzpatrick's stock trading: frequently asked questions
What stocks does Michael G. Fitzpatrick trade the most?
Michael G. Fitzpatrick's most frequently disclosed positions are COV (Covidien plc. ordinary Shares, 2 trades), DD (DuPont de Nemours, Inc., 1 trade), CL (Colgate-Palmolive Company, 1 trade), based on official House financial disclosures.
How many stock trades has Michael G. Fitzpatrick disclosed?
Michael G. Fitzpatrick has disclosed 18 stock trades since 2013 — 8 purchases and 10 sales worth an estimated $168,500 at the midpoints of the disclosed ranges.
When did Michael G. Fitzpatrick last trade stocks?
The most recent transaction Michael G. Fitzpatrick disclosed was on Apr 10, 2015. Members of Congress must report trades within 45 days under the STOCK Act, so new filings can lag the trade itself.
Is it legal for Michael G. Fitzpatrick to trade stocks?
Yes — members of Congress may trade stocks, but the 2012 STOCK Act requires them to publicly disclose every trade over $1,000 within 45 days. This page tracks Michael G. Fitzpatrick's disclosures and links to the original filings.
Other active members of Congress
Thomas MacArthur
Republican · NJ
1299 trades
Gilbert Cisneros
Democrat · CA
1193 trades
Josh Gottheimer
Democrat · NJ
1161 trades
Susie Lee
Democrat · NV
850 trades
Greg Gianforte
Republican · MT
746 trades
Alan S. Lowenthal
Democrat · CA
687 trades
Lisa McClain
Republican · MI
664 trades
Lois Frankel
Democrat · FL
625 trades
Source: Michael G. Fitzpatrick's official US House Periodic Transaction Report filings. Amounts are disclosed as ranges; estimates use range midpoints. Data may be delayed or contain filer errors. Updated Aug 13, 2026. Not investment advice.